Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain

Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J

ClinicoEconomics and Outcomes Research 2023, 15:659-671

Published Date: 7 September 2023